Zepbound in Australia: Why It's Called Mounjaro Here (2026 Guide)
Key Takeaways
Searching for Zepbound in Australia? It's the same medication as Mounjaro — tirzepatide — sold under a different name. What Zepbound is, why the US has two brands, and how Australians access tirzepatide in 2026.
If you've been reading American weight loss forums, watching TikTok, or following US health news, you've seen the name Zepbound everywhere. Then you search "Zepbound Australia" and find… almost nothing. Here's why: Zepbound and Mounjaro are the same medication — tirzepatide — and in Australia it is sold only under the Mounjaro brand.
Zepbound vs Mounjaro: same drug, different label
Both are made by Eli Lilly, and both contain identical tirzepatide. In the United States, Lilly registered the drug twice: Mounjaro for type 2 diabetes, and Zepbound for chronic weight management. Same molecule, same pen technology, same doses (2.5mg through 15mg weekly) — the split exists mostly for US insurance reasons, because American insurers cover diabetes drugs and weight loss drugs differently.
Australia doesn't have that insurance structure, so Lilly simply registered Mounjaro here with the TGA — and Australian doctors can prescribe it for weight management where clinically appropriate.
Can you buy Zepbound in Australia?
Not under that name — and you don't need to. Any Australian pharmacy that stocks Mounjaro is selling exactly what Americans buy as Zepbound. If a website offers to ship you "Zepbound" to Australia, be extremely cautious: importing prescription medicines bought from overseas websites is risky, frequently illegal without the right approvals, and a common vector for counterfeit products. The safe, legal route is a prescription for Mounjaro from an Australian-registered doctor.
Want to know if Mounjaro is right for you?
Our GPs can assess your suitability for tirzepatide via bulk billed telehealth. No referral, no waiting room.
Is Zepbound (tirzepatide) available in Australia for weight loss?
Yes — as Mounjaro. Tirzepatide is TGA-registered and available in Australian pharmacies for weight management, prescribed where clinically appropriate: generally a BMI of 30 or above, or 27+ with a weight-related condition such as high blood pressure, sleep apnoea or prediabetes. Assessment happens through a normal GP consultation, which is exactly what our telehealth service provides — bulk billed for eligible Medicare card holders, Australia-wide.
What the Zepbound trials mean for Australian patients
The clinical evidence Americans cite for Zepbound applies identically to Mounjaro, because it is the same drug. In the SURMOUNT-1 trial, participants on the highest tirzepatide dose lost an average of around 20% of body weight over 72 weeks — the strongest result of any approved weight loss medication. Head-to-head data also suggests tirzepatide outperforms semaglutide (Wegovy) on average weight loss; see our Wegovy vs Mounjaro comparison for how the two stack up in practice.
How much does tirzepatide cost in Australia?
Mounjaro is a private prescription (not PBS-subsidised for weight loss), with monthly costs from roughly $230 at the 2.5mg starting dose to $460 at the 15mg maximum, varying by pharmacy. Full dose-by-dose pricing is in our Mounjaro pharmacy price guide.
How do I get a prescription?
The same way you'd get any prescription — a GP consultation. Ours are done via telehealth: request an appointment, complete a short health questionnaire, and speak with an AHPRA-registered GP by phone or video. If tirzepatide is clinically appropriate for you, your eScript is sent electronically the same day to your preferred pharmacy.
For the complete picture on tirzepatide in Australia — how it works, side effects, eligibility and results — read our full Mounjaro Australia guide and tirzepatide explainer.
Wondering if Mounjaro is right for you?
Request an appointment and our GPs will assess your suitability for tirzepatide — bulk billed through Medicare. No referral required.
Book a Consultation